Online edition of India's National Newspaper
Friday, Jul 27, 2007
ePaper
Google



Business
News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Jobs | Obituary |



Business Printer Friendly Page   Send this Article to a Friend

GSK Pharma divests unit

Staff Correspondent

Thermo Electron to pay Rs. 240 cr. for buying QFC division

MUMBAI: The board of directors of GlaxoSmithKline Pharmaceuticals (GSK Pharma) approved the divestment of the company’s Qualigens Fine Chemicals (QFC) business to Thermo Electron LLS India Private Ltd., a subsidiary of Thermo Fisher Scientific Inc., a leading American company, for a consideration of Rs. 240 crore.

QFC, a division of GSK Pharma, makes and markets a range of fine chemicals, diagnostic kits and laboratory products, including glassware, culture media, instruments and filter papers.

Thermo Fisher Scientific, with revenues of $9 billion, is the leading provider of analytical instruments, laboratory equipment, reagents and consumables, software and services for research, analysis, discovery and diagnostics. As part of its continued focus on establishing a greater presence in the Asian region, the company is looking to establish a strong foundation in India for making available its extensive range of products to the fast growing Indian market.

Hasit Joshipura, Managing Director, GSK Pharma, said, “under the GSK umbrella, QFC has had an excellent track record which has enabled the business to develop into a market leader in its area, with great contributions from its excellent and skilled workforce.”

Printer friendly page  
Send this article to Friends by E-Mail



Business

News: ePaper | Front Page | National | Tamil Nadu | Andhra Pradesh | Karnataka | Kerala | New Delhi | Other States | International | Opinion | Business | Sport | Miscellaneous | Engagements |
Advts:
Classifieds | Jobs | Obituary | Updates: Breaking News |

Trip Mela Dell


News Update


The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | Publications | eBooks | Images | Home |

Copyright © 2007, The Hindu. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu